Qing Sarah Yuan
Chief Tech/Sci/R&D Officer at SIGILON THERAPEUTICS, INC.
Qing Sarah Yuan active positions
| Companies | Position | Start | End |
|---|---|---|---|
| SIGILON THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 06/03/2022 | - |
Career history of Qing Sarah Yuan
Former positions of Qing Sarah Yuan
| Companies | Position | Start | End |
|---|---|---|---|
| BIOVERATIV INC | Corporate Officer/Principal | 31/12/2016 | 31/12/2018 |
| 2SEVENTY BIO, INC. | Corporate Officer/Principal | - | - |
Training of Qing Sarah Yuan
| University of Wisconsin | Doctorate Degree |
| University of California, Berkeley | Undergraduate Degree |
Statistics
International
| United States | 6 |
Operational
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| SIGILON THERAPEUTICS, INC. | Health Technology |
| 2SEVENTY BIO, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Bioverativ, Inc.
 Bioverativ, Inc. BiotechnologyHealth Technology Bioverativ, Inc. is a global biopharmaceutical company, focused on discovery, research, development and commercialization of therapies for the treatment of blood diseases including hemophilia. The company is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Qing Sarah Yuan
- Experience